ocular disorder
University of Manchester, Sano Genetics to Research Eye Diseases
The partners plan to build a database of genomic and patient-reported data to identify how genetics can impact disease outcome.
Avellino Labs Gets CLIA Certification
With the certification, the Silicon Valley-based company aims to roll out its AvaGen test for keratoconus and corneal dystrophies beginning this quarter.
Editas, Allergan Ink $90M CRISPR-Based Eye Drug Deal
Allergan will have the exclusive rights to license certain of Editas' CRISPR genome editing-based treatments for eye diseases.
Scientists Exploit SNP to Create New CRISPR/Cas9 Editing Site in Corneal Dystrophy Gene
They successfully edited the gene in mice in vivo and their approach could also work for a range of heterozygous disease-causing SNPs.
Exome sequencing poorly covers some known disease genes, but identifies novel genes that that Harvard team thinks will help improve panel's diagnostic rate.